GLP-1 receptor agonist 14
|
|
GLP-1 receptor agonist 14 Eigenschaften
- Dichte
- 1.569±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
- pka
- 5.726±0.20(predicted)
Sicherheit
GLP-1 receptor agonist 14 Chemische Eigenschaften,Einsatz,Produktion Methoden
GLP-1 receptor agonist 14 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
GLP-1 receptor agonist 14 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 4)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Changzhou Yongfeng Biomedicine Co. Ltd. | 15006117673 |
2973592490@qq.com | China | 304 | 58 |
Shanghai Guangyang Carrie Biotechnology Co., LTD | 18616826356 |
1942593824@qq.com | China | 1454 | 58 |
Nantong QuanYi Biotechnology Co., Ltd | 0513-66337626 18051384581 |
sales@chemhifuture.com | China | 5656 | 58 |
- GLP-1 receptor agonist 14
- 1,2,4-Oxadiazol-5(2H)-one, 3-[1-[2-[[(4S)-2-(3-cyclopropyl-4-fluorophenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-7-(tetrahydro-2,2-dimethyl-2H-pyran-4-yl)-3-indolizinyl]cyclopropyl]-
- 2758659-09-3